Skip to content

Omnicell OMCL Free cash flow

Free cash flow at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$546M
Cardinal Health logo
Cardinal HealthCAH
$1.68B-40.0%
Cencora logo
CencoraCOR
-$2.42B+14.2%
ICU Medical logo
ICU MedicalICUI
$27.61M-24.8%
Haemonetics logo
HaemoneticsHAE
$53.28M-47.2%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%

Valuation

See full
Market cap$1.75B-7.2%
Enterprise value$1.49B-0.4%
P/E113.2×
P/S1.4×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Calculated from Omnicell’s reported figures.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's free cash flow?
Omnicell (OMCL) reported free cash flow of $42.07M in Q1 2026.
How has Omnicell's free cash flow changed year-over-year?
Omnicell's free cash flow increased by 185.1% year-over-year, from $14.75M to $42.07M.
What is the long-term trend for Omnicell's free cash flow?
Over 4 years (2021 to 2025), Omnicell's free cash flow has grown at a -19.1% compound annual growth rate (CAGR), from $202.84M to $86.89M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.